- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01649973
Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy
January 2, 2014 updated by: Mi Ja Yun, MD, PhD, National Medical Center, Seoul
Laryngeal view of the patient and anesthesiologist's discomfort level during endotracheal intubation in relation to the various heights of operating table has not been investigated.
The investigators hypothesis is higher table height will improve the laryngeal exposure.
Study Overview
Status
Completed
Conditions
Detailed Description
Eight anesthesiologists will be participated.
For each anesthesiologist, 20 patients will be enrolled and they will be randomly allocated into one of 4 groups; T10, T8, T6 or T4.
The height of operating table will be adjusted prior to commencement of anesthesia induction to place the patient's forehead at one of four anesthesiologist's dermatome levels (T10, T8, T6 or T4) depending on the group.
The best laryngeal views will be graded before and after the anesthesiologist's postural change to improve laryngeal visualization of the patient during intubation.
Subjective and objective measurement of anesthesiologists' joint flexion during intubation and discomfort ratings for the mask ventilation or intubation will be recorded.
Study Type
Observational
Enrollment (Actual)
8
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
certificated anesthesiologists
Description
Inclusion Criteria:
- have experiences of more than 100 cases of endotracheal intubation
Exclusion Criteria:
- have acute or chronic musculoskeletal disease or pain
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
larynx
Time Frame: larynx
|
larynx
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Mija Yun, National Medical Center, Seoul
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
March 1, 2011
Study Registration Dates
First Submitted
July 23, 2012
First Submitted That Met QC Criteria
July 24, 2012
First Posted (Estimate)
July 25, 2012
Study Record Updates
Last Update Posted (Estimate)
January 3, 2014
Last Update Submitted That Met QC Criteria
January 2, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Other Study ID Numbers
- SeoulNUBH-B-1003-096-012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Larynx
-
University of Texas Southwestern Medical CenterCompletedEarly-stage Glottic Larynx CancerUnited States
-
Mayo ClinicSuspendedLarynx | Larynx Disease | Laryngectomy | Larynx Stenosis | Larynx FractureUnited States
-
Latin American Cooperative Oncology GroupMerck Sharp & Dohme LLCActive, not recruitingSquamous Cell Carcinoma of LarynxBrazil
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedHuman Papilloma Virus Infection | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage III Verrucous Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage... and other conditionsUnited States
-
University of LeipzigUniversity of Kiel; University of Cologne; University of Jena; Technical University... and other collaboratorsRecruitingLaryngeal Cancer | Squamous Cell Carcinoma of Head and Neck | Laryngeal Neoplasms | Squamous Cell Carcinoma of the Larynx | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Laryngectomy; Status | Squamous Cell Carcinoma of Larynx | Squamous Cell Carcinoma of the Larynx Stage... and other conditionsGermany
-
Danish Head and Neck Cancer GroupCompletedHNSCC,Larynx, Pharynx and Oral CavityDenmark
-
Hacettepe UniversityCompletedLarynx Cancer | Larynx CarcinomaTurkey
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedTongue Cancer | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Oropharynx | Stage III Verrucous Carcinoma of the Larynx | Stage IV Squamous Cell Carcinoma of the Hypopharynx | Stage IVA Squamous... and other conditionsUnited States
-
University Hospitals Cleveland Medical CenterCompleted
-
Radboud University Medical CenterDutch Cancer SocietyCompleted